Demo · Report

Hybrid Report

Combined clinical and technical report: quick reference card, global EEG summary, vigilance data, site metrics, connectivity, and protocol recommendations in one document.

Back to demoDownload raw TXT
Sample data only. This report is from an anonymous test run for demonstration purposes. It is not from a real client session.

Neurofeedback practitioners

Hybrid Report

Sample output from demo run — generated by EEG Paradox Decoder v1.0.4

# EEG PARADOX REPORT

CLINICAL SNAPSHOT

Primary Network AffectedFrontal
Overall Pattern SeverityHigh deviation
Dominant FeaturesAlpha suppression, elevated Theta/Beta
Laterality BiasLeft > Right (22:8)
Cross-Network InvolvementCentral, Frontal, Occipital, Parietal
Interpretive ConfidenceHigh(consistent findings across sites)

## Table of Contents

  1. 1
    [Patient Overview](#1-patient-overview)
  2. 2
    [Global EEG Summary](#2-global-eeg-summary)

2.5. [Vigilance State Analysis](#25-vigilance-state-analysis)

  1. 1
    [Site-Specific Metrics](#3-site-specific-metrics)
  2. 2
    [Connectivity Metrics](#4-connectivity-metrics)
  3. 3
    [Vigilance & Arousal Metrics](#5-vigilance--arousal-metrics)
  4. 4
    [Advanced Metrics](#6-advanced-metrics)
  5. 5
    [Statistical Analysis](#7-statistical-analysis)
  6. 6
    [Phenotype Classification](#8-phenotype-classification)
  7. 7
    [Neurofeedback Recommendations](#9-neurofeedback-recommendations)
  8. 8
    [Visualization Appendix](#10-visualization-appendix)
  9. 9
    [Summary Sheet](#11-summary-sheet)

## Quick Reference Card

**Most Critical Finding**🔴 SEVERE F3 Low Alpha(EO) at F3
**Global Vigilance State**Unknown (V0)
**Primary Phenotype**Frontal Alpha Suppression Pattern
**Suggested Protocol**Consider posterior alpha enhancement(O1, O2, Pz) with natural spread OR frontal alpha normalization if asymmetry present (8-12 Hz) (Swingle)

## Key Takeaways

**Summary of Most Important Points**
  1. 1
    30 high-deviation finding(s) detected – clinical review recommended
  2. 2
    Frontal network shows the most significant patterns (13 findings)
  3. 3
    Clinical correlation with patient history and symptoms is essential
  4. 4
    Consider neurofeedback protocols based on network-specific findings

## 1. Patient Overview

  • **Client ID**: anonymous
  • **Age/Gender**: Not specified, Not specified
  • **Session Date**: Not specified
  • **Recording Type**: single_paired
  • **Normative Framework(s)**: cuban2ndwave

## 2. Global EEG Summary

  • **Baseline Rhythms**:
  • Dominant Alpha Frequency: 10.25 Hz
  • Overall Amplitude Range: 4.0-7.1 µV
  • **State Markers (Vigilance Model)**:
  • Arousal Level: 50.0 (normal range)
  • Vigilance Level: V0 (confidence: 0.00)
  • Dominant Vigilance State: Drowsy

## 2.5. Vigilance State Analysis

### Global Vigilance State

  • **Dominant State**: Drowsy
  • **Vigilance Index**: 50.0 (0-100 scale)
  • **Level**: V0
  • **Confidence**: 0.00

## 3. Site-Specific Metrics ### Site: C3

  • Delta (1-4 Hz): 4.39 µV
  • Theta (4-8 Hz): 2.84 µV
  • Alpha (8-12 Hz): 2.65 µV
  • SMR (12-15 Hz): 1.58 µV
  • Beta (12-30 Hz): 2.69 µV
  • HiBeta (22-30 Hz): 1.68 µV
  • Gamma (30+ Hz): 1.54 µV
  • Ratios: Theta/Beta=1.06, Alpha/Theta=0.93, Beta/Alpha=1.01, Beta/Total=0.403, Fast/Slow=0.46
  • Relative Power: Beta=16.3%, Alpha=16.0%, Theta=18.5%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: C3 Left Motor Control Deficit (EO), C3 Left Motor Relaxation Deficit (EC)
**Phenotypic Marker**None identified
### SiteC4
  • Delta (1-4 Hz): 3.49 µV
  • Theta (4-8 Hz): 2.33 µV
  • Alpha (8-12 Hz): 2.51 µV
  • SMR (12-15 Hz): 1.40 µV
  • Beta (12-30 Hz): 2.33 µV
  • HiBeta (22-30 Hz): 1.54 µV
  • Gamma (30+ Hz): 1.27 µV
  • Ratios: Theta/Beta=1.00, Alpha/Theta=1.08, Beta/Alpha=0.93, Beta/Total=0.408, Fast/Slow=0.53
  • Relative Power: Beta=17.4%, Alpha=20.2%, Theta=17.8%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: C4 Right Motor Control Deficit (EO), C4 Right Motor Relaxation Deficit (EC)
**Phenotypic Marker**None identified
### SiteCz
  • Delta (1-4 Hz): 4.05 µV
  • Theta (4-8 Hz): 2.65 µV
  • Alpha (8-12 Hz): 2.75 µV
  • SMR (12-15 Hz): 1.44 µV
  • Beta (12-30 Hz): 2.49 µV
  • HiBeta (22-30 Hz): 1.62 µV
  • Gamma (30+ Hz): 1.32 µV
  • Ratios: Theta/Beta=1.06, Alpha/Theta=1.04, Beta/Alpha=0.91, Beta/Total=0.389, Fast/Slow=0.45
  • Relative Power: Beta=15.8%, Alpha=19.3%, Theta=18.3%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: Low Alpha (Possible Stress or Trauma), Peniston Low Beta (Alcohol Use), Chemo Brain Alpha Deficiency
**Phenotypic Marker**None identified
### SiteF3
  • Delta (1-4 Hz): 3.64 µV
  • Theta (4-8 Hz): 2.37 µV
  • Alpha (8-12 Hz): 2.42 µV
  • SMR (12-15 Hz): 1.33 µV
  • Beta (12-30 Hz): 2.46 µV
  • HiBeta (22-30 Hz): 1.61 µV
  • Gamma (30+ Hz): 1.26 µV
  • Ratios: Theta/Beta=0.96, Alpha/Theta=1.02, Beta/Alpha=1.02, Beta/Total=0.427, Fast/Slow=0.54
  • Relative Power: Beta=18.8%, Alpha=17.9%, Theta=17.5%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: F3 Low Alpha(EO), F3 Migraine Active Phase (EO), Frontal Alpha Asymmetry (EO) - Mild
**Phenotypic Marker**None identified
### SiteF4
  • Delta (1-4 Hz): 3.86 µV
  • Theta (4-8 Hz): 2.45 µV
  • Alpha (8-12 Hz): 2.55 µV
  • SMR (12-15 Hz): 1.48 µV
  • Beta (12-30 Hz): 2.37 µV
  • HiBeta (22-30 Hz): 1.60 µV
  • Gamma (30+ Hz): 1.30 µV
  • Ratios: Theta/Beta=1.03, Alpha/Theta=1.04, Beta/Alpha=0.93, Beta/Total=0.397, Fast/Slow=0.47
  • Relative Power: Beta=16.3%, Alpha=18.5%, Theta=17.4%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: F4 Low Alpha (EO), F4 Migraine Active Phase (EO), F4 Low Alpha (EC)
**Phenotypic Marker**None identified
### SiteF7
  • Delta (1-4 Hz): 3.49 µV
  • Theta (4-8 Hz): 2.01 µV
  • Alpha (8-12 Hz): 2.04 µV
  • SMR (12-15 Hz): 1.17 µV
  • Beta (12-30 Hz): 2.26 µV
  • HiBeta (22-30 Hz): 1.49 µV
  • Gamma (30+ Hz): 1.62 µV
  • Ratios: Theta/Beta=0.89, Alpha/Theta=1.01, Beta/Alpha=1.11, Beta/Total=0.423, Fast/Slow=0.62
  • Relative Power: Beta=18.4%, Alpha=14.6%, Theta=14.5%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Phenotypic Marker**None identified
### SiteF8
  • Delta (1-4 Hz): 3.95 µV
  • Theta (4-8 Hz): 2.21 µV
  • Alpha (8-12 Hz): 2.15 µV
  • SMR (12-15 Hz): 1.34 µV
  • Beta (12-30 Hz): 2.07 µV
  • HiBeta (22-30 Hz): 1.33 µV
  • Gamma (30+ Hz): 1.42 µV
  • Ratios: Theta/Beta=1.07, Alpha/Theta=0.97, Beta/Alpha=0.96, Beta/Total=0.366, Fast/Slow=0.40
  • Relative Power: Beta=13.8%, Alpha=14.5%, Theta=15.8%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Phenotypic Marker**None identified
### SiteFp1
  • Delta (1-4 Hz): 4.46 µV
  • Theta (4-8 Hz): 2.14 µV
  • Alpha (8-12 Hz): 2.07 µV
  • SMR (12-15 Hz): 1.14 µV
  • Beta (12-30 Hz): 2.04 µV
  • HiBeta (22-30 Hz): 1.34 µV
  • Gamma (30+ Hz): 1.27 µV
  • Ratios: Theta/Beta=1.05, Alpha/Theta=0.97, Beta/Alpha=0.99, Beta/Total=0.345, Fast/Slow=0.31
  • Relative Power: Beta=12.1%, Alpha=12.3%, Theta=13.2%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Within normal limits
**Phenotypic Marker**None identified
### SiteFp2
  • Delta (1-4 Hz): 4.54 µV
  • Theta (4-8 Hz): 2.23 µV
  • Alpha (8-12 Hz): 2.15 µV
  • SMR (12-15 Hz): 1.25 µV
  • Beta (12-30 Hz): 2.03 µV
  • HiBeta (22-30 Hz): 1.34 µV
  • Gamma (30+ Hz): 1.28 µV
  • Ratios: Theta/Beta=1.10, Alpha/Theta=0.96, Beta/Alpha=0.94, Beta/Total=0.337, Fast/Slow=0.30
  • Relative Power: Beta=11.5%, Alpha=12.7%, Theta=13.9%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Within normal limits
**Phenotypic Marker**None identified
### SiteFz
  • Delta (1-4 Hz): 3.75 µV
  • Theta (4-8 Hz): 2.49 µV
  • Alpha (8-12 Hz): 2.59 µV
  • SMR (12-15 Hz): 1.42 µV
  • Beta (12-30 Hz): 2.39 µV
  • HiBeta (22-30 Hz): 1.57 µV
  • Gamma (30+ Hz): 1.26 µV
  • Ratios: Theta/Beta=1.04, Alpha/Theta=1.04, Beta/Alpha=0.92, Beta/Total=0.403, Fast/Slow=0.48
  • Relative Power: Beta=16.7%, Alpha=19.4%, Theta=18.3%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: Frontal Beta Deficiency (Fz EC), PTSD/CPTSD Low Alpha (Fz EC), PTSD/CPTSD Disrupted Beta (Fz EC)
**Phenotypic Marker**None identified
### SiteO1
  • Delta (1-4 Hz): 3.20 µV
  • Theta (4-8 Hz): 2.31 µV
  • Alpha (8-12 Hz): 3.10 µV
  • SMR (12-15 Hz): 1.90 µV
  • Beta (12-30 Hz): 2.79 µV
  • HiBeta (22-30 Hz): 1.49 µV
  • Gamma (30+ Hz): 1.52 µV
  • Ratios: Theta/Beta=0.83, Alpha/Theta=1.34, Beta/Alpha=0.90, Beta/Total=0.456, Fast/Slow=0.79
  • Relative Power: Beta=21.7%, Alpha=26.2%, Theta=15.5%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: Anxiety Risk, Occipital Alpha Deficiency, Low Theta/Beta (O1 EO)
**Phenotypic Marker**None identified
### SiteO2
  • Delta (1-4 Hz): 3.32 µV
  • Theta (4-8 Hz): 2.22 µV
  • Alpha (8-12 Hz): 3.24 µV
  • SMR (12-15 Hz): 1.74 µV
  • Beta (12-30 Hz): 2.66 µV
  • HiBeta (22-30 Hz): 1.42 µV
  • Gamma (30+ Hz): 1.42 µV
  • Ratios: Theta/Beta=0.83, Alpha/Theta=1.46, Beta/Alpha=0.82, Beta/Total=0.442, Fast/Slow=0.69
  • Relative Power: Beta=19.8%, Alpha=28.3%, Theta=14.3%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: O2 Migraine Active Phase (EO), O2 Low Alpha (EC)
**Phenotypic Marker**None identified
### SiteP3
  • Delta (1-4 Hz): 3.36 µV
  • Theta (4-8 Hz): 2.31 µV
  • Alpha (8-12 Hz): 2.41 µV
  • SMR (12-15 Hz): 1.46 µV
  • Beta (12-30 Hz): 2.39 µV
  • HiBeta (22-30 Hz): 1.30 µV
  • Gamma (30+ Hz): 1.31 µV
  • Ratios: Theta/Beta=0.97, Alpha/Theta=1.04, Beta/Alpha=0.99, Beta/Total=0.430, Fast/Slow=0.55
  • Relative Power: Beta=18.9%, Alpha=19.2%, Theta=18.1%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: P3 Left Parietal Relaxation Deficit (EO), P3 Left Parietal Relaxation Deficit (EC)
**Phenotypic Marker**None identified
### SiteP4
  • Delta (1-4 Hz): 3.42 µV
  • Theta (4-8 Hz): 2.27 µV
  • Alpha (8-12 Hz): 2.68 µV
  • SMR (12-15 Hz): 1.56 µV
  • Beta (12-30 Hz): 2.33 µV
  • HiBeta (22-30 Hz): 1.34 µV
  • Gamma (30+ Hz): 1.27 µV
  • Ratios: Theta/Beta=0.98, Alpha/Theta=1.18, Beta/Alpha=0.87, Beta/Total=0.406, Fast/Slow=0.52
  • Relative Power: Beta=17.3%, Alpha=22.7%, Theta=17.0%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: P4 Right Parietal Relaxation Deficit (EO), P4 Right Parietal Relaxation Deficit (EC)
**Phenotypic Marker**None identified
### SiteP7
  • Delta (1-4 Hz): 2.87 µV
  • Theta (4-8 Hz): 1.94 µV
  • Alpha (8-12 Hz): 2.30 µV
  • SMR (12-15 Hz): 1.42 µV
  • Beta (12-30 Hz): 2.27 µV
  • HiBeta (22-30 Hz): 1.35 µV
  • Gamma (30+ Hz): 1.56 µV
  • Ratios: Theta/Beta=0.85, Alpha/Theta=1.18, Beta/Alpha=0.99, Beta/Total=0.450, Fast/Slow=0.79
  • Relative Power: Beta=20.7%, Alpha=20.8%, Theta=15.4%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Phenotypic Marker**None identified
### SiteP8
  • Delta (1-4 Hz): 3.00 µV
  • Theta (4-8 Hz): 2.02 µV
  • Alpha (8-12 Hz): 2.65 µV
  • SMR (12-15 Hz): 1.47 µV
  • Beta (12-30 Hz): 2.22 µV
  • HiBeta (22-30 Hz): 1.24 µV
  • Gamma (30+ Hz): 1.33 µV
  • Ratios: Theta/Beta=0.91, Alpha/Theta=1.31, Beta/Alpha=0.83, Beta/Total=0.417, Fast/Slow=0.63
  • Relative Power: Beta=18.1%, Alpha=25.5%, Theta=16.1%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Phenotypic Marker**None identified
### SitePz
  • Delta (1-4 Hz): 3.66 µV
  • Theta (4-8 Hz): 2.44 µV
  • Alpha (8-12 Hz): 2.69 µV
  • SMR (12-15 Hz): 1.54 µV
  • Beta (12-30 Hz): 2.40 µV
  • HiBeta (22-30 Hz): 1.32 µV
  • Gamma (30+ Hz): 1.29 µV
  • Ratios: Theta/Beta=1.02, Alpha/Theta=1.10, Beta/Alpha=0.89, Beta/Total=0.403, Fast/Slow=0.47
  • Relative Power: Beta=16.7%, Alpha=21.0%, Theta=17.6%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: Pz Low Alpha (EC)
**Phenotypic Marker**None identified
### SiteT7
  • Delta (1-4 Hz): 3.26 µV
  • Theta (4-8 Hz): 2.08 µV
  • Alpha (8-12 Hz): 2.10 µV
  • SMR (12-15 Hz): 1.28 µV
  • Beta (12-30 Hz): 2.04 µV
  • HiBeta (22-30 Hz): 1.27 µV
  • Gamma (30+ Hz): 1.47 µV
  • Ratios: Theta/Beta=1.02, Alpha/Theta=1.01, Beta/Alpha=0.97, Beta/Total=0.400, Fast/Slow=0.53
  • Relative Power: Beta=16.3%, Alpha=17.1%, Theta=17.0%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: T3 Low Alpha (EC), PTSD/CPTSD Low Alpha (T3 EC), PTSD/CPTSD Disrupted Beta (T3 EC)
**Phenotypic Marker**None identified
### SiteT8
  • Delta (1-4 Hz): 2.94 µV
  • Theta (4-8 Hz): 1.71 µV
  • Alpha (8-12 Hz): 1.91 µV
  • SMR (12-15 Hz): 1.16 µV
  • Beta (12-30 Hz): 1.77 µV
  • HiBeta (22-30 Hz): 1.12 µV
  • Gamma (30+ Hz): 1.22 µV
  • Ratios: Theta/Beta=0.97, Alpha/Theta=1.12, Beta/Alpha=0.93, Beta/Total=0.390, Fast/Slow=0.51
  • Relative Power: Beta=15.7%, Alpha=18.1%, Theta=15.2%
  • **Alpha Sub-Band Analysis**: Ratio=1.000, Pattern=balanced
**Interpretation**Primary findings: T4 Low Alpha (EC), PTSD/CPTSD Low Alpha (T4 EC), PTSD/CPTSD Disrupted Beta (T4 EC)
**Phenotypic Marker**None identified

## 4. Connectivity Metrics ### Coherence Matrices

  • No coherence matrices available

#### Coherence Summary

  • **Key Hypo-Coherences** (<0.3): None identified
  • **Key Hyper-Coherences** (>0.7): None identified

### Phase-Amplitude Coupling (PAC)

  • No PAC data available

### Cross-Frequency Coupling (CFC)

  • No CFC data available

## 5. Vigilance & Arousal Metrics

  • **Alpha Suppression Response**: Not available (single epoch)
  • **Beta Spindling**: Not significant
  • **Foggy Thinking Marker**: Not available

## 6. Advanced Metrics

  • Detrended Fluctuation Analysis (DFA): Not calculated
  • Entropy (Sample, Permutation): Not calculated
  • Fractal Dimension (FD): Not calculated
  • Phase-Lag Index (PLI): Not calculated (requires multi-channel analysis)

## 7. Statistical Analysis

  • **Z-Score Summary (Across Sites & Bands)**:
  • Highest z-scores: Cz Theta (EO) (z=-2.80), Cz Delta (EO) (z=-2.08), Cz HiBeta (EO) (z=-6.50), Cz Gamma (EO) (z=-10.01), Cz Theta/Beta (EO) (z=-2.89), Cz Theta (EC) (z=-3.18), Cz Delta (EC) (z=-2.53), Cz HiBeta (EC) (z=-6.62), Cz Gamma (EC) (z=-9.97), Cz Theta/Beta (EC) (z=-3.25)
  • Notable z-score anomalies: Cz Theta (EO): severe, Cz HiBeta (EO): severe, Cz Gamma (EO): severe, Cz Theta/Beta (EO): severe, Cz Theta (EC): severe, Cz Delta (EC): severe, Cz HiBeta (EC): severe, Cz Gamma (EC): severe, Cz Theta/Beta (EC): severe, F3 Theta (EO): severe

## 8. Phenotype Classification

  • **Primary EEG Phenotype(s)**: Frontal Alpha Suppression Pattern
  • **Jungian Archetype (Optional)**: Not mapped

## 9. Neurofeedback Recommendations

  • **Target Sites**: C3, C4, Cz, F3, F4, F7, F8, Fz, O1, O2
  • **Training Bands**: To be determined
  • **Protocol Suggestions**:
  • Swingle: Standard protocols
  • Phenotypes: Standard strategies
  • Fisher (Trauma-Oriented): Occipital Alpha Suppression (PTSD/Trauma), Low Alpha (Possible Stress or Trauma)
  • **Cascade Model Implications**:
  • Anticipated Downstream Effects: Downstream effects from Frontal Alpha Suppression Pattern pattern, Downstream effects from Occipital Alpha Suppression Pattern pattern, Downstream effects from Occipital Theta Suppression Pattern pattern

## 10. Meta Commentary (Optional)

  • Literature Cross-Reference:
  • ADHD: [Budzynski et al., 2009]
  • Depression: [Swingle, 2015]
  • Trauma: [Fisher, 2013]
  • System Validation Status: Automated quantitative analysis

## 11. Visualization Appendix

  • **Topographical Maps**: Available in visualizations/ directory
  • Band power topomaps (Delta, Theta, Alpha, Beta, Gamma, SMR, HiBeta)
  • Absolute and relative power topomaps
  • Z-score topomaps (clinical significance maps)
  • Multi-band topomap grid
  • Side-by-side EO/EC comparison topomaps
  • **FFT Power Spectra**: Available in visualizations/ directory
  • Per-channel frequency spectra (WinEEG-style grid)
  • Color-coded frequency bands
  • Side-by-side EO/EC comparison spectra
  • **Vigilance Hypnograms**: Available in visualizations/ directory
  • 7-state vigilance timeline
  • State transitions and confidence plots
  • EO/EC epoch-specific hypnograms (when available)
  • **Visualization Manifest**: visualization_manifest.json (lists all generated visualizations)

## 12. Summary Sheet (1-page)

MarkerLocationZ-scoreInterpretationProtocol
Bipolar Disorder - Depressive EpisodeF3N/AmoderateStandard
Left Frontal Attention DifficultyF3N/AmoderateStandard
F3 Low Alpha (EO)F3N/ANoneStandard
F3 Migraine Active Phase (EO)F3N/ANoneStandard
Frontal Alpha Asymmetry (EO) - MildF3N/AmildStandard
Frontal Alpha Asymmetry (EO) - ModerateF3N/AmoderateStandard
Frontal Alpha Asymmetry (EO) - SevereF3N/AsevereStandard
Bipolar Disorder - Manic EpisodeF4N/AmoderateStandard
Right Frontal Attention DifficultyF4N/AmoderateStandard
F4 Low Alpha (EO)F4N/ANoneStandard
F4 Migraine Active Phase (EO)F4N/ANoneStandard
C3 Left Motor Control DeficitC3N/AmoderateStandard
C3 Left Motor Control Deficit (EO)C3N/ANoneStandard
C4 Right Motor Control DeficitC4N/AmoderateStandard
C4 Right Motor Control Deficit (EO)C4N/ANoneStandard
P3 Left Parietal Processing DeficitP3N/AmoderateStandard
P3 Left Parietal Relaxation Deficit (EO)P3N/ANoneStandard
P4 Right Parietal Processing DeficitP4N/AmoderateStandard
P4 Right Parietal Relaxation Deficit (EO)P4N/ANoneStandard
Anxiety RiskO1N/ANoneStandard

---

Report generated2026-03-04 00:49:24

EEG Paradox Clinical Pattern Detection System

More in Protocol & Treatment

Protocol Suggestions

Neurofeedback practitioners

Protocol Flow

Technicians, pipeline operators

All outputs shown are from sample data for illustration only. EEG Paradox Solutions provides non-clinical informational services. Licensed clinicians interpret the results.